{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T19:44:55Z","timestamp":1773258295033,"version":"3.50.1"},"reference-count":24,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Clin Oncol"],"DOI":"10.3892\/mco.2021.2401","type":"journal-article","created":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T12:28:14Z","timestamp":1632140894000},"source":"Crossref","is-referenced-by-count":11,"title":["Pleural effusion and multiple myeloma\u00a0\u2011\u00a0more than meets the eye: A case report"],"prefix":"10.3892","volume":"15","author":[{"given":"Ana","family":"Ramos","sequence":"first","affiliation":[{"name":"Pulmonology Department, Egas Moniz Hospital, 1349\u2011019\u00a0Lisbon, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Trindade","sequence":"additional","affiliation":[{"name":"Medicine Department, Fernando Fonseca Hospital, 2720\u2011276\u00a0Amadora, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Pinto","sequence":"additional","affiliation":[{"name":"Medicine Department, West Hospital Center\u2011Torres Vedras, 2560\u2011324\u00a0Torres Vedras, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Brand\u00e3o","sequence":"additional","affiliation":[{"name":"Department of Pathological Anatomy, University Hospital Center of Porto, 4099\u2011901\u00a0Porto, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e1udia","family":"Pedrosa","sequence":"additional","affiliation":[{"name":"Department of Clinical Hematology, University Hospital Center of Porto, 4099\u2011901\u00a0Porto, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Pinto","sequence":"additional","affiliation":[{"name":"Department of Intensive Care, University Hospital Center of Porto, 4099\u2011901\u00a0Porto, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2021,9,20]]},"reference":[{"key":"key20211013103224_b1-MCO-15-5-02401","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/leu.2011.29","article-title":"Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myeloma","volume":"25","author":"Short","year":"2011","journal-title":"Leukemia"},{"key":"key20211013103224_b2-MCO-15-5-02401","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the world health organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2017","journal-title":"Blood"},{"key":"key20211013103224_b3-MCO-15-5-02401","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1056\/NEJMra041875","article-title":"Multiple myeloma","volume":"351","author":"Kyle","year":"2004","journal-title":"N Engl J Med"},{"key":"key20211013103224_b4-MCO-15-5-02401","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1159\/000477793","article-title":"Pleural effusion in multiple myeloma: Characteristics and practice patterns","volume":"138","author":"Byun","year":"2017","journal-title":"Acta Haematol"},{"key":"key20211013103224_b5-MCO-15-5-02401","doi-asserted-by":"publisher","first-page":"339","DOI":"10.2169\/internalmedicine.55.4733","article-title":"Pleural effusion in multiple myeloma","volume":"55","author":"Wang","year":"2016","journal-title":"Intern Med"},{"key":"key20211013103224_b6-MCO-15-5-02401","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/archinte.1978.03630290039015","article-title":"Thoracic and pulmonary abnormalities in multiple myeloma. A review of 958 Cases","volume":"138","author":"Kintzer","year":"1978","journal-title":"Arch Intern Med"},{"key":"key20211013103224_b7-MCO-15-5-02401","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1373\/clinchem.2010.160994","article-title":"Pleural effusion in a patient with multiple myeloma","volume":"58","author":"Oudart","year":"2012","journal-title":"Clin Chem"},{"key":"key20211013103224_b8-MCO-15-5-02401","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.1200\/JCO.2011.34.9290","article-title":"Soft-tissue plasmacytomas in multiple myeloma: Incidence, mechanisms of extramedullary spread, and treatment approach","volume":"29","author":"Blad\u00e9","year":"2011","journal-title":"J Clin Oncol"},{"key":"key20211013103224_b9-MCO-15-5-02401","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.3109\/10428194.2012.740562","article-title":"Extramedullary multiple myeloma","volume":"54","author":"Weinstock","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"key20211013103224_b10-MCO-15-5-02401","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/j.1600-0609.2010.01504.x","article-title":"Extensive soft-tissue involvement by plasmablastic myeloma arising from displaced humeral fractures","volume":"85","author":"De Larrea","year":"2010","journal-title":"Eur J Haematol"},{"key":"key20211013103224_b11-MCO-15-5-02401","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1378\/chest.125.4.1546","article-title":"Pleural effusions in hematologic malignancies","volume":"125","author":"Alexandrakis","year":"2004","journal-title":"Chest"},{"key":"key20211013103224_b12-MCO-15-5-02401","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1378\/chest.105.2.622","article-title":"Pleural effusion in multiple myeloma","volume":"105","author":"Rodriguez","year":"1994","journal-title":"Chest"},{"key":"key20211013103224_b13-MCO-15-5-02401","first-page":"68","article-title":"Myelomatous pleural effusion","volume":"6","author":"Shirdel","year":"2007","journal-title":"Tanaffos"},{"issue":"bcr2016215433","key":"key20211013103224_b14-MCO-15-5-02401","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2016-215433","article-title":"Pleural effusion as a manifestation of multiple myeloma","volume":"12","author":"Iqbal","year":"2016","journal-title":"BMJ Case Rep"},{"key":"key20211013103224_b15-MCO-15-5-02401","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ccm.2012.11.006","article-title":"The light criteria: The beginning and why they are useful 40 years later","volume":"34","author":"Light","year":"2013","journal-title":"Clin Chest Med"},{"key":"key20211013103224_b16-MCO-15-5-02401","first-page":"1234","article-title":"The phenotype of normal, reactive and malignant plasma cells. Identification of \u2018many and multiple myelomas\u2019 and of new targets for myeloma therapy","volume":"91","author":"Bataiile","year":"2006","journal-title":"Haematologica"},{"key":"key20211013103224_b17-MCO-15-5-02401","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1182\/blood-2015-07-635383","article-title":"How I treat extramedullary myeloma","volume":"127","author":"Touzeau","year":"2016","journal-title":"Blood"},{"key":"key20211013103224_b18-MCO-15-5-02401","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/bjh.13382","article-title":"Development of extramedullary myeloma in the era of novel agents: No evidence of increased risk with lenalidomide-bortezomib combinations","volume":"169","author":"Varga","year":"2015","journal-title":"Br J Haematol"},{"key":"key20211013103224_b19-MCO-15-5-02401","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.3324\/haematol.2012.065698","article-title":"Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents","volume":"97","author":"Usmani","year":"2012","journal-title":"Haematologica"},{"key":"key20211013103224_b20-MCO-15-5-02401","doi-asserted-by":"publisher","first-page":"ii61","DOI":"10.1136\/thx.2010.137026","article-title":"Pleural procedures and thoracic ultrasound: British thoracic society pleural disease guideline 2010","volume":"65 (Suppl 2)","author":"Havelock","year":"2010","journal-title":"Thorax"},{"key":"key20211013103224_b21-MCO-15-5-02401","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1080\/10428190500102845","article-title":"Malignant pleural effusion of multiple myeloma: Prognostic factors and outcome","volume":"46","author":"Kamble","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"key20211013103224_b22-MCO-15-5-02401","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1159\/000165694","article-title":"Multiple myeloma with myelomatous pleural effusion: A case report and review of the literature","volume":"120","author":"Kim","year":"2008","journal-title":"Acta Haematol"},{"key":"key20211013103224_b23-MCO-15-5-02401","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/(sici)1097-0339(20000301)22:3<147::aid-dc3>3.0.co;2-6","article-title":"Cytology and flow cytometry of malignant effusions of multiple myeloma","volume":"22","author":"Palmer","year":"2000","journal-title":"Diagn Cytopathol"},{"key":"key20211013103224_b24-MCO-15-5-02401","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/j.1365-2141.2007.06735.x","article-title":"Use of intrapleural bortezomib in myelomatous pleural effusion","volume":"139","author":"Iannitto","year":"2007","journal-title":"Br J Haematol"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"deposited":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T13:31:02Z","timestamp":1634131862000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mco.2021.2401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,20]]},"references-count":24,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,9,20]]}},"URL":"https:\/\/doi.org\/10.3892\/mco.2021.2401","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,20]]},"article-number":"238"}}